The analysis looks at the mortality rate for those who continued or started ACEi/ARB treatment and those who discontinued or did not initiate the treatment. Withdrawal of angiotensin-converting enzyme ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalized COVID-19 patients with hypertension and on treatment with an renin-angiotensin system ...

A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current ...

Patients who had been taking an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) for preexisting hypertension had lower in-hospital mortality but stayed longer in ...

kidney Risk of mortality in HF patients with reduced kidney function taking ACE inhibitors and ARBs were evaluated. WASHINGTON, DC—According to data presented at the ACC.17 Scientific Session, ...

Researchers in India have conducted a meta-analysis investigating the effects of using angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) on outcomes among ...

Certain high blood pressure medications may help reduce the severity of disease and mortality rates for those infected with the novel coronavirus, according to a new study published in the journal ...

(HealthDay News) — Nonadherence to angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) and/or statins following acute myocardial infarction (AMI) is associated with ...

—Getting kidney patients to stick with an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) presents a real challenge. Here are some tips that may help. When it ...

In more than 3 million people worldwide treated for hypertension, ARBs were not only just as effective as ACE inhibitors at reducing the risk of major cardiovascular events, but also associated with a ...

Blockade of the renin-angiotensin-aldosterone-system with either an angiotensin receptor blocker (ARB) or angiotensin-converting enzyme (ACE) inhibitor provides similar protection from cardiovascular ...

Since the introduction of ARBs, the question that has pervaded each clinician’s mind is whether or not these drugs serve an advantage in conditions long addressed by ACE inhibitors. Matchar et al ...